Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (06): 28-33    DOI: Q819
    
The Experimental Study of Preventive Effects from hTM Gene for Neointima Formation and Stenosis in Rabbit Artery Injury-block Model
DA Yi1,HUANG Xiao-ling2,MENG Min1,LI Jing-dong1,SHI De2
1.The Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China
2.The First Affiliated Hospital of Chongqing Medical University,Chongqing 400014,China
Download: HTML   PDF(2090KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To observe neointima formation in rabbit artery injury-block model which were transferred by pcDNA3.1/hTM plasmids. Methods: After transferred pcDNA3.1/hTM plasmid into rabbit artery by high-pressure injection, rabbit common iliac artery were cut and anastomosed again. The expression of hTM protein at vessels wall were examined with immunohistochemistry at 3d,7d,14d and 28d after operation. At the 14d and 28d after second operation, the inside diameter of anastomotic stoma and blood flow velocity were checked by color Doppler. The treated artery were sliced and stained by Verhoeff. Local neointima formation and the ratio stenosis of intervascular was calculated by computer. Result: The expression of hTM was at higher level in hTM gene treated group than vector treated group and control group at 3day, 7day, 14day, 28day after second operation. At 7day, the level was highest. At 14day and 28day, Color Doppler showed that the stoma bore were 1.93mm±0.34mm(14d),1.89mm±0.28mm(28d) in hTM gene treated group;1.59mm±0.43mm(14d),1.38mm±0.28mm(28d) in vector treated group;1.46mm0.25mm,1.44mm±0.32mm in control group. The ratio stoensis were 32%±23%(14d),37%±14%(28d) in hTM gene treated group;58%±21%(14d),63%±17% in vector treated group;58%±19%(14d),61%±23%(28d) in the control group,respectively. Conclusion: Human thrombmodulin gene could reduce the neointima formation and vascular stoensis in rabbit artery injury-block model.



Key wordsThrombomodulin      Gene      Artery vessel      Stenosis     
Received: 08 January 2010      Published: 12 June 2010
Corresponding Authors: dai yi     E-mail: chinadaiyi@yahoo.com.cn
Cite this article:

DAI Yi, HUANG Xiao-Ling, MENG Min, LI Jing-Dong, SHI De. The Experimental Study of Preventive Effects from hTM Gene for Neointima Formation and Stenosis in Rabbit Artery Injury-block Model. China Biotechnology, 2010, 30(06): 28-33.

URL:

https://manu60.magtech.com.cn/biotech/Q819     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I06/28

[1] Zhang Z Y, Yin X H. Impact of adenovirus-mediated local expression of human tissue factor pathway inhibitor on vascular smooth muscular cell proliferation and apoptosis in the stent-implanted femoral artery of the rabbit. J Int Med Res,2008,36(3):567571. 
[2] Cui W, Wilson J T, Wen J,et al. Thrombomodulin improves early outcomes after intraportal islet transplantation. Am J Transplant,2009,9(6):13081316. 
[3] 戴毅, 陈开, 邹琳,等.人血栓调节蛋白基因编码片段的克隆及在真核细胞中的表达.中国普外基础与临床杂志, 2005,12(6): 577580. Dai Y,Chen K,Zou L,et al.Chin J Bases Clin General Surg,2005,12(6):577580. 
[4] J.萨姆布鲁克,D.W.拉塞尔著 黄培堂等译。分子克隆实验指南(上册).第三版. 北京:科学出版社,2002.128-129. Sambrook J,MacCallum P.Molecular Cloning:A Laboratory Manual.3rd ed.Beijing:Science Press,2002.128129. 
[5] Kopp C W, Hlzenbein T, Steiner S, et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. Blood,2004,103(5):16531661. 
[6] Lijnen H R, Van Hoef B, Umans K,et al. Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1). J Thromb Haemost,2004,2(1):1622. 
[7] Grenier G, Rémy-Zolghadri M, Bergeron F, et al. Mechanical loading modulates the differentiation state of vascular smooth muscle cells. Tissue Eng,2006,12(11):31593170. 
[8] Qu Y, Shi X, Zhang H, et al. VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery.J Vasc Surg,2009,50(6):14521458. 
[9] Wen O, Dittman W T, Ye R D, et al. Human thrombomodulin complete cDNA sequence and chromosome localization of the gene. Biochem,1987,26(14):43504357. 
[10] Di Cera E.Thrombin as procoagulant and anticoagulant.Thromb Haemost,2007,5(Suppl 1):196202. 
[11] Elphick G F, Sarangi P P, Hyun Y M, et al. Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood,2009,113(17):40784085. 
[12] Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide- induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost,2002,88(2):267273. 
[13] Sturn D H, Kaneider N C, Feistritzer C, et al. Expression and function of the endothelial protein C receptor in human neutrophils. Blood,2003,102(4):14991505.

[1] LI Xiao-jin,LI Yan-meng,LI Zhen-kun,XU An-jian,YANG Xiao-xi,HUANG Jian. The Mechanism of Copper Accumulation Induced Autophagy in Hepatocytes of ATP7B-deficient Mice Based on RNA-sequencing[J]. China Biotechnology, 2021, 41(9): 10-19.
[2] MA Ning,WANG Han-jie. Advances of Optogenetics in the Regulation of Bacterial Production[J]. China Biotechnology, 2021, 41(9): 101-109.
[3] HUANG Huan-bang,WU Yang,YANG You-hui,WANG Zhao-guan,QI Hao. Progress in Incorporation of Non-canonical Amino Acid Based on Archaeal Tyrosyl-tRNA Synthetase[J]. China Biotechnology, 2021, 41(9): 110-125.
[4] WU Xiu-zhi,WANG Hong-jie,ZU Yao. Functional Study of hoxa1a Regulating Craniofacial Bone Development in Zebrafish[J]. China Biotechnology, 2021, 41(9): 20-26.
[5] HE Li-heng,ZHANG Yi,ZHANG Jie,REN Yu-chao,XIE Hong-e,TANG Rui-min,JIA Xiao-yun,WU Zong-xin. Construction of Gene Co-expression Network and Identification of Hub Genes Related to Anthocyanin Biosynthesis Based on RNA-seq and WGCNA in Sweetpotato[J]. China Biotechnology, 2021, 41(9): 27-36.
[6] CHEN Ya-chao,LI Nan-nan,LIU Zi-di,HU Bing,LI Chun. Metagenomic Mining of Functional Genes Related to Glycyrrhizin Synthesis from Endophytes of Licorice[J]. China Biotechnology, 2021, 41(9): 37-47.
[7] YANG Liu,MOU Hao,XU Guo-yang,BAI Yun-chuan,YU Yuan-di. Analysis of the Difference in Color Development of Cultured Goatpox Virus Common Cells in X-gal Environment[J]. China Biotechnology, 2021, 41(9): 48-54.
[8] ZHAO Xiao-yu,XU Qi-ling,ZHAO Xiao-dong,AN Yun-fei. Enhancing Lentiviral Vector Transduction Efficiency for Facilitating Gene Therapy[J]. China Biotechnology, 2021, 41(8): 52-58.
[9] YANG Wan-bin,XU Yan,ZHUO Shi-xuan,WANG Xin-yi,LI Ya-jing,GUO Yi-fan,ZHANG Zheng-guang,GUO Yuan-yuan. Progress of Long Non-coding RNAs Related Epigenetic Modifications in Cancer[J]. China Biotechnology, 2021, 41(8): 59-66.
[10] GUO Man-man,TIAN Kai-ren,QIAO Jian-jun,LI Yan-ni. Application of Phage Recombinase Systems in Synthetic Biology[J]. China Biotechnology, 2021, 41(8): 90-102.
[11] Bao-qi FENG,Jiao FENG,Miao ZHANG,Yang LIU,Rui CAO,Han-zhi YIN,Feng-xian QI,Zi-long LI,Shou-liang YIN. Screening of High Avermectin-producing Strains via Tn5 Transposon Mediated Mutagenesis[J]. China Biotechnology, 2021, 41(7): 32-41.
[12] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[13] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[14] LIANG Jin-gang,ZHANG Xu-dong,BI Yan-zhe,WANG Hao-qian,ZHANG Xiu-jie. Development Status and Prospect of Genetically Modified Insect-resistant Maize[J]. China Biotechnology, 2021, 41(6): 98-104.
[15] HU Xuan,WANG Song,YU Xue-ling,ZHANG Xiao-peng. Construction of a Destabilized EGFP Cell Model for Gene Editing Evaluation[J]. China Biotechnology, 2021, 41(5): 17-26.